会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 67. 发明授权
    • Novel D-homosteroids
    • 新型D-类固醇激素
    • US4578475A
    • 1986-03-25
    • US573983
    • 1984-01-26
    • Andor FurstMarcel MullerUlrich KerbRudolf Wiechert
    • Andor FurstMarcel MullerUlrich KerbRudolf Wiechert
    • A61K31/15A61K31/275C07J63/00C07J71/00C07D211/70C07D307/94
    • C07J71/001C07J63/008C07J71/0047C07J71/0063
    • The novel D-homosteroids of the formula ##STR1## wherein R.sup.1 represents a --CN, .dbd.NOH or .dbd.CH--NHOH group; R.sup.2 represents oxo or, where R.sup.1 represents a --CN group, R.sup.2 represents oxo or a --OAc group; or R.sup.1 and R.sup.2 together with carbon atoms 2 and 3 of the steroid skeleton represents a [2,3-d]-fused isoxazole ring, a [3,2-c]-fused pyrazole ring, a [3,2-c]-fused N-acylated pyrazole ring or a [2,3-c]-fused furazan ring; Ac represents an acyl group; R.sup.3 and R.sup.4 represent methyl and R.sup.5 and R.sup.6 together represent an additional bond between carbon atoms 5 and 6 of the steroid skeleton; or R.sup.4 and R.sup.5 together represent --O--, R.sup.3 represents hydrogen or methyl, and R.sup.6 represents hydrogen; R.sup.7 represents hydrogen, lower-alkyl or ethynyl; R.sup.8 represents hydroxy or acyloxy; or R.sup.7 and R.sup.8 together represent a spiroether group of the formula ##STR2## or a spirolactone group of the formula ##STR3## the dotted 16,17-bond is an optional additional carbon-carbon bond; and the dotted 2,3-bond is an additional carbon-carbon bond when R.sup.1 and R.sup.2 together with carbon atoms 2 and 3 form the isoxazole or pyrazole ring or when R.sup.2 represents a --OAc group,inhibit the synthesis of progesterone in organisms and can be used for fertility control. The novel D-homosteroids can be manufactured by molecular modifications of other D-homosteroids.
    • 式中,R1表示-CN,= NOH或= CH-NHOH基团的新型D-类固醇类化合物。 R 2表示氧代,或其中R 1表示-CN基,R 2表示氧代或-OCc基; 或R 1和R 2与类固醇骨架的碳原子2和3一起代表[2,3-d] - 稠合的异恶唑环,[3,2-c] - 引入的吡唑环,[3,2-c] - 引入的N-酰化吡唑环或[2,3-c] - 呋喃环; Ac表示酰基; R3和R4表示甲基,R5和R6一起代表类固醇骨架的碳原子5和6之间的附加键; 或R 4和R 5一起表示-O-,R 3表示氢或甲基,R 6表示氢; R7表示氢,低级烷基或乙炔基; R8表示羟基或酰氧基; 或者R 7和R 8一起表示式Ia的螺醚基或式Ia的螺内酯基团,点缀的16,17-键是任选的另外的碳 - 碳键; 当R 1和R 2与碳原子2和3一起形成异恶唑或吡唑环时,或当R 2表示-OAc基团时,虚线的2,3-键是另外的碳 - 碳键,抑制生物体中孕酮的合成, 用于生育控制。 新型D-类固醇可以通过其他D-类固醇激素的分子修饰来制造。
    • 69. 发明授权
    • 5.beta.-Hydroxy-.DELTA..sup.6 -steroids and process for the preparation
thereof
    • 5β-羟基-DTATA 6-类固醇及其制备方法
    • US4472310A
    • 1984-09-18
    • US359713
    • 1982-03-11
    • Dieter BittlerHenry LaurentKlaus NickischRobert NickolsonRudolf Wiechert
    • Dieter BittlerHenry LaurentKlaus NickischRobert NickolsonRudolf Wiechert
    • C07J1/00C07J21/00C07J53/00C07J71/00
    • C07J21/003C07J1/0025C07J53/008C07J71/001
    • The disclosure concerns 5.beta.-hydroxy-.DELTA..sup.6 -steroids of the general formula ##STR1## wherein R.sup.1 is hydrogen, acyl, lower alkyl, or the tetrahydropyranyl residue andR.sup.2, R.sup.3 individually are respectively hydrogen or jointly are methylene andX stands for oxygen, the groupings ##STR2## (wherein R.sup.4 means hydrogen or acyl) and ##STR3## (wherein R.sup.5 means hydrogen or lower alkyl) and a process for the preparation thereof by reacting corresponding 7.alpha.-chloro-5.beta.,6.beta.-epoxy steroids in an inert solvent with metallic zinc in a lower aliphatic carboxylic acid or dilute mineral acid at temperatures of between room temperature and 100.degree. C., preferably at 40.degree.-70.degree. C.The compounds producible by this method are intermediates for the preparation of 3-keto-.DELTA..sup.4 -6.beta.,7.beta.-methylene steroids constituting pharmacologically valuable compounds, for example aldosterone antagonists.
    • PCT No.PCT / DE81 / 00111 Sec。 371日期1982年3月11日 102(e)1982年3月11日PCT PCT。 公开号WO82 / 00294 日本1982年2月4日。该公开内容涉及通式为“IMAGE”的5ββ-羟基-DTATA-类固醇,其中R 1为氢,酰基,低级烷基或四氢吡喃基,R2,R3分别为氢或共同 (其中R 4表示氢或酰基)和(其中R 5表示氢或低级烷基)及其制备方法,通过使相应的7α- 氯代-5β,6β-环氧类固醇在惰性溶剂中与金​​属锌在低级脂族羧酸或稀无机酸中在室温至100℃之间,优选40℃-70℃的温度下进行。化合物 通过该方法可生产的是制备构成药理学上有价值的化合物的3-酮-TATA4-6β,7β-亚甲基甾族化合物的中间体,例如醛固酮拮抗剂。